HomeTSHA • NASDAQ
add
Taysha Gene Therapies Inc
Previous close
$2.56
Day range
$2.56 - $2.77
Year range
$1.05 - $4.32
Market cap
553.65M USD
Avg Volume
2.96M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.30M | -32.51% |
Operating expense | 23.72M | -14.48% |
Net income | -21.53M | 10.52% |
Net profit margin | -935.23 | -32.58% |
Earnings per share | -0.07 | 23.87% |
EBITDA | -21.14M | 11.94% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 116.59M | -5.96% |
Total assets | 138.36M | -9.57% |
Total liabilities | 83.30M | -15.98% |
Total equity | 55.06M | — |
Shares outstanding | 214.66M | — |
Price to book | 9.48 | — |
Return on assets | -35.85% | — |
Return on capital | -42.54% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -21.53M | 10.52% |
Cash from operations | -22.02M | -11.22% |
Cash from investing | -371.00K | -165.00% |
Cash from financing | -52.00K | -136.36% |
Net change in cash | -22.44M | -12.44% |
Free cash flow | -14.82M | -38.54% |
About
Founded
2019
Headquarters
Website
Employees
73
